James Richard Porter sold $2.1M of Nuvalent (NUVL)

Executed Jun 16 2025, disclosed Jun 17 2025, 1 day later.

Value, as filed

$2.1M

26,800 sh across 2 lots

Executed

Jun 16 2025

the trade date, as filed

Disclosed

Jun 17 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

James Richard Porter President and CEO profile →

James Richard Porter (President and CEO) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Nuvalent Inc (NUVL). The largest single filing was $3.7M of NUVL (30,000 sh × $123.72, as filed), executed Jul 6.

The name

NUVL

Nuvalent Inc NUVL · Healthcare · 94 filings in 24 months ticker →

Healthcare · Nuvalent, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by James Richard Porter in NUVL

NUVLSALE Nuvalent Inc $3.7M
30,000 sh × $123.72
Exec Jul 6
Filed Jul 8 · 4:30 PM ET NUVLSALE Nuvalent Inc $2.7M
30,000 sh across 3 lots
Exec Jun 8
Filed Jun 10 · 5:30 PM ET NUVLSALE Nuvalent Inc $3.1M
30,000 sh across 5 lots
Exec May 4
Filed May 6 · 5:30 PM ET NUVLSALE Nuvalent Inc $3.1M
29,900 sh across 3 lots
Exec Apr 6
Filed Apr 8 · 5:30 PM ET NUVLSALE Nuvalent Inc $2.9M
29,600 sh across 2 lots
Exec Mar 6
Filed Mar 10 · 5:30 PM ET NUVLSALE Nuvalent Inc $2.6M
26,758 sh across 6 lots
Exec Jan 5
Filed Jan 7 · 5:30 PM ET NUVLSALE Nuvalent Inc $2.4M
26,300 sh across 3 lots
Exec Oct 16 2025
Filed Oct 17 2025 · 5:30 PM ET NUVLSALE Nuvalent Inc $2.1M
27,000 sh across 3 lots
Exec Sep 15 2025
Filed Sep 17 2025 · 5:30 PM ET